Cholangiocarcinoma (Bile Duct Cancer): Symptoms, Causes, and Treatment
Updated: 3 days ago
Medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026
Quick Answer: What is cholangiocarcinoma?
Cholangiocarcinoma is a cancer that forms in the bile ducts, the tubes that carry bile from the liver to the small intestine. Warning signs include jaundice, itchy skin, white stools and dark urine, but early stages cause few symptoms, so it is often found late. Surgery is the main hope for a cure, alongside other therapies depending on stage. [1] [2]
What the research says
According to PubMed:
Bile duct cysts and stones, cirrhosis, and hepatitis B and C are among the strongest risk factors. A systematic review and meta-analysis of 25 case-control studies from 7 countries, covering 13 risk factors, found that biliary cysts and stones, cirrhosis, and hepatitis B and C were the strongest risk factors for both intrahepatic and extrahepatic cholangiocarcinoma. Choledochal cysts carried pooled odds ratios of 26.71 (95% CI 15.80 to 45.16) for intrahepatic and 34.94 (95% CI 24.36 to 50.12) for extrahepatic disease, while hypertension and obesity showed no significant association. (Clements et al., DOI).
Adding immunotherapy to chemotherapy improved survival in advanced biliary tract cancer. In the phase 3 TOPAZ-1 trial of 685 patients with advanced biliary tract cancer, which includes bile duct cancer, adding durvalumab to gemcitabine plus cisplatin lowered the risk of death (hazard ratio 0.80, 95% CI 0.66 to 0.97), with estimated 24-month overall survival of 24.9% versus 10.4% on chemotherapy plus placebo and objective response rates of 26.7% versus 18.7%. (Oh et al., DOI).
Liver transplant can offer long-term survival for carefully selected patients. A patient-level meta-analysis compared liver transplant for intrahepatic and perihilar cholangiocarcinoma and for selected liver metastases (103 to 721 patients per indication) with 112,014 conventional liver transplants from the UNOS database. Five-year overall survival ranged from 53.3% to 68.6% across the four indications, particularly when performed under validated selection criteria such as Mayo-like protocols for perihilar cholangiocarcinoma. (Ciria et al., DOI).
Study details are from PubMed abstracts.
What does "cholangiocarcinoma" actually mean?
Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the slender tubes that carry bile — the digestive fluid produced by your liver. The bile ducts connect your liver to your gallbladder and to your small intestine, where bile helps break down fat in the food you eat. [1]
The disease occurs mostly in people older than 50, though it can occur at any age. It is often diagnosed when it is advanced, which is exactly what makes successful treatment so difficult to achieve. [1]
The word breaks into two parts: "cholangio" refers to the bile ducts, and "carcinoma" means a cancer that starts in the lining cells of an organ. Cholangiocarcinoma happens when cells in the bile ducts develop changes in their DNA. The DNA changes tell the cells to multiply out of control and form a mass — a tumor — that can invade and destroy healthy body tissue. [1]
To understand where the cancer forms, it helps to know what bile ducts do. Your liver makes a yellow-green fluid called bile, which flows into the gallbladder where it is stored until it is needed. When you eat, the gallbladder releases bile into the bile duct, and the duct carries it to the duodenum — the upper part of the small intestine — to break down fat in food. [1]
Key fact | What to know |
What it is | Cancer of the bile ducts (the tubes carrying digestive fluid bile) |
Also called | Bile duct cancer |
Who it affects | Mostly adults over 50, though it can occur at any age |
Where it forms | Inside the liver (intrahepatic), just outside the liver (hilar), or nearest the small intestine (distal) |
Hallmark symptom | Jaundice — yellowing of the skin and the whites of the eyes |
Why treatment is hard | Often diagnosed at an advanced stage |
Possible curative paths | Surgery and, for some hilar tumors, liver transplant |
What are the types of bile duct cancer?
Doctors divide cholangiocarcinoma into three types based on where the cancer occurs in the bile duct system. [1]
Type | Also called | Where it occurs |
Intrahepatic cholangiocarcinoma | — | In the parts of the bile ducts within the liver; sometimes classified as a type of liver cancer |
Hilar cholangiocarcinoma | Perihilar cholangiocarcinoma | In the bile ducts just outside of the liver, at the point where the ducts leave the liver |
Distal cholangiocarcinoma | Extrahepatic cholangiocarcinoma | In the portion of the bile duct nearest the small intestine |
The type matters enormously for treatment. Intrahepatic tumors may be approached like some liver cancers. Hilar tumors sit at a surgical crossroads where the ducts exit the liver, making some of them candidates for liver transplant. Distal tumors sit closest to the intestine, which changes the surgical approach.
What are the symptoms of cholangiocarcinoma?
The classic symptom cluster of bile duct cancer comes from blocked bile flow. When a tumor narrows or blocks a bile duct, bilirubin — the pigment in bile — backs up into the bloodstream and stains the skin and eyes yellow.
Signs and symptoms of cholangiocarcinoma include jaundice (yellowing of the skin and the whites of the eyes), intensely itchy skin, white-colored stools, fatigue, abdominal pain on the right side just below the ribs, unexplained weight loss, fever, night sweats, and dark urine. [1]
Not every person will have all of these signs, and early disease may produce none at all. That silence is the central problem with this cancer: by the time symptoms such as jaundice and pain force someone to seek care, the tumor has often progressed.
When to see a doctor
See your doctor if you have persistent fatigue, abdominal pain, jaundice, or other signs and symptoms that bother you. Your doctor may refer you to a specialist in digestive diseases called a gastroenterologist. [1] Persistent, unexplained jaundice in particular should always prompt prompt evaluation.
What causes cholangiocarcinoma?
At the cellular level, cholangiocarcinoma begins when cells in the bile ducts develop changes in their DNA. A cell's DNA contains the instructions that tell a cell what to do. The changes tell the cells to multiply out of control and form a tumor that can invade and destroy healthy body tissue. It is not clear what causes the changes that lead to cholangiocarcinoma. [1]
What is clear is that several factors raise the odds of those changes occurring. The known risk factors cluster heavily around conditions that inflame, scar, or irritate the bile ducts and liver over years.
What are the risk factors for cholangiocarcinoma?
Cholangiocarcinoma risk factors, such as primary sclerosing cholangitis and chronic liver disease, share long-term irritation, scarring or inflammation of the bile ducts and liver.
Risk factor | What it is and why it matters |
Primary sclerosing cholangitis | A disease that causes hardening and scarring of the bile ducts; one of the strongest known risk factors |
Chronic liver disease | Scarring of the liver caused by a history of chronic liver disease increases risk |
Bile duct problems present at birth | People born with a choledochal cyst, which causes dilated and irregular bile ducts, have an increased risk |
A liver parasite | In parts of Southeast Asia, cholangiocarcinoma is associated with liver fluke infection, which can occur from eating raw or undercooked fish |
Older age | Occurs most often in adults over age 50 |
Smoking | Smoking is associated with an increased risk |
Diabetes | People with type 1 or type 2 diabetes may have an increased risk |
Certain inherited conditions | Some DNA changes passed from parents to children increase risk; examples include cystic fibrosis and Lynch syndrome |
Having a risk factor is not a diagnosis. Many people with one or more of these risks never develop bile duct cancer, and some people diagnosed with it have none of them. What these factors share is a common thread: long-term irritation, scarring, or inflammation of the bile ducts and liver. [1]
Can cholangiocarcinoma be prevented?
Not entirely — several major risk factors, such as age, genetics, and birth-related bile duct cysts, cannot be controlled. But a few concrete steps lower the risk of the factors you can influence. [1]
If you smoke, stopping is the single most actionable step, because smoking is linked to an increased risk of cholangiocarcinoma. If quitting attempts have failed in the past, ask your doctor about strategies that help.
You can also reduce your risk of liver disease, since chronic liver disease is tied to higher cancer risk. Some causes of liver disease cannot be prevented, but others can. To lower the risk of cirrhosis (liver inflammation and scarring), drink alcohol in moderation — up to one drink a day for women and up to two drinks a day for men for healthy adults — maintain a healthy weight, and follow safety instructions when working with chemicals. [1]
How is cholangiocarcinoma diagnosed?
Diagnosing bile duct cancer is a careful, multi-step process, because the tumors are deep inside the abdomen and their symptoms overlap with many less-serious conditions. If your doctor suspects cholangiocarcinoma, one or more of the following tests will be part of the workup. [2]
Diagnostic test | What it does |
Liver function tests | Blood tests that measure how well your liver is working and give clues about what is causing your symptoms |
Tumor marker test (CA 19-9) | Measures a protein called carbohydrate antigen 19-9, which bile duct cancer cells overproduce; a high level is a clue, not a diagnosis — it can also rise with other bile duct diseases such as inflammation or obstruction |
ERCP (endoscopic retrograde cholangiopancreatography) | A thin, flexible tube with a tiny camera is passed down your throat to your small intestine to examine where the bile ducts connect; dye can be injected through it to highlight the ducts on X-ray images |
Imaging tests | Ultrasound, CT scans, and MRI combined with MRCP (magnetic resonance cholangiopancreatography); MRCP is increasingly used as a noninvasive alternative to ERCP because it produces 3D images without injecting dye |
Endoscopic ultrasound | An endoscope fitted with an ultrasound device at its tip is passed down the throat; it emits sound waves that generate images of nearby tissues |
Biopsy | A small tissue sample is removed and examined under a microscope to confirm cancer; obtained during ERCP if the suspicious area is near the intestine, or by fine-needle aspiration through the skin if it is within or near the liver, guided by endoscopic ultrasound or CT |
One biopsy caution deserves special attention: if your bile duct cancer is biopsied by fine-needle aspiration, you become ineligible for liver transplantation. [2] For that reason, the method of biopsy matters when transplant may be a future option — a question worth raising with your care team early.
Once cancer is confirmed, your doctor works to determine the extent, or stage, of the disease, often with additional imaging tests. The stage helps determine your prognosis and your treatment options. [2] And because this is a difficult cancer to treat, do not hesitate to ask about your doctor's experience with diagnosing it — and get a second opinion if you have any doubts. [2]
How is cholangiocarcinoma treated?
Treatment options depend on the cancer's type, location, and stage. The overall goal is to remove as much cancer as possible when that is achievable, and to slow the disease and relieve symptoms when it is not. [2]
Treatment | What it involves | When it is used |
Surgery | Removing as much of the cancer as possible: for very small tumors, removing part of the bile duct and joining the cut ends; for more-advanced cancers, nearby liver tissue, pancreas tissue, or lymph nodes may also be removed | When the cancer is localized enough to be operable |
Liver transplant | Removing your liver and replacing it with one from a donor | In certain situations for hilar cholangiocarcinoma; for many, transplant can be a cure — but cancer can recur afterward |
Chemotherapy | Drugs that kill cancer cells, given through a vein to travel throughout the body or delivered directly to the cancer cells | Before a liver transplant; or for advanced cancer to slow the disease and relieve symptoms |
Radiation therapy | High-powered energy beams (from X-rays or protons) directed at the cancer; either external beam radiation or brachytherapy, in which radioactive material is placed inside the body near the cancer site | As a primary or supporting treatment depending on the case |
Targeted drug therapy | Drugs that block specific abnormalities within cancer cells, causing the cells to die; your cancer cells may be tested to see if this approach will work | When testing shows targetable abnormalities |
Immunotherapy | Treatments that use your immune system to fight cancer by interfering with the proteins cancer cells use to hide from immune cells | For advanced cancer, often given with chemotherapy as a first treatment |
Radiofrequency ablation | Electric current heats and destroys cancer cells through thin needles inserted through small incisions in the abdomen, guided by imaging such as ultrasound | To destroy small, targeted areas of cancer |
Photodynamic therapy | A light-sensitive chemical is injected into a vein and accumulates in fast-growing cancer cells; laser light directed at the cancer triggers a reaction that kills the cells | To relieve symptoms and possibly slow growth; multiple treatments are typically needed, and sun exposure must be avoided afterward |
Biliary drainage | Restoring the flow of bile using a thin tube placed into the bile duct, bypass surgery to reroute bile around the cancer, or stents that hold open a duct collapsed by cancer | To relieve the symptoms of blocked bile flow |
Clinical trials
Clinical trials are studies that test new treatments, such as new drugs and new approaches to surgery. If a studied treatment proves safer and more effective than current options, it can become the new standard of care. Trials cannot guarantee a cure and might have serious or unexpected side effects, but they are closely monitored for safety and can offer access to treatments that would otherwise be unavailable. [2] Talk to your doctor about whether a clinical trial is appropriate for you.
Supportive (palliative) care
Palliative care is specialized medical care focused on relief from pain and other symptoms of a serious illness. Palliative care specialists work with you, your family, and your other doctors as an extra layer of support that complements ongoing treatment — including aggressive treatments such as surgery. [2]
An important and hopeful finding: when palliative care is used alongside other appropriate treatments, even soon after diagnosis, people with cancer may feel better and may live longer. Palliative care is provided by teams of doctors, nurses, and other trained professionals whose goal is improving quality of life. It is not the same as hospice care or end-of-life care. [2]
Conclusion: a difficult cancer, but not an untreatable one
Cholangiocarcinoma is cancer of the bile ducts, and it most often affects adults over 50. Its hallmark warning signs — jaundice, intensely itchy skin, white stools, and dark urine — result from blocked bile flow, and because early disease is so quiet, the cancer is frequently found at an advanced stage. The causes of the underlying DNA changes remain unclear, but known risks such as primary sclerosing cholangitis, chronic liver disease, smoking, and diabetes point to a pattern of long-term bile duct and liver irritation.
Treatment is demanding and depends heavily on tumor location and stage, yet meaningful options exist: surgery, liver transplant for select hilar tumors, chemotherapy, radiation, targeted therapy, immunotherapy, ablation, and bile drainage that restores comfort. Second opinions and experienced care teams are not optional extras — they are standard practice for this disease.
Next steps: If you or a loved one has persistent jaundice, right-sided abdominal pain, unexplained weight loss, or severe itching that will not lift, contact a healthcare professional promptly and ask about liver function testing and imaging. If bile duct cancer has been diagnosed, ask about your doctor's experience treating it, consider a second opinion, ask whether your tumor is surgically removable or transplant-eligible, ask which tests your cancer cells should undergo for targeted therapy, and ask about palliative care from day one.
Frequently asked questions
Is cholangiocarcinoma the same as bile duct cancer?
Yes. Cholangiocarcinoma is the medical term for bile duct cancer — a cancer that forms in the slender tubes (bile ducts) that carry the digestive fluid bile from your liver to your small intestine. [1]
Is cholangiocarcinoma the same as liver cancer?
Sometimes, but usually no. The intrahepatic type forms inside the liver and is sometimes classified as a liver cancer. However, the more common hilar and distal types form outside the liver. The liver and the bile ducts are different organs, so treatment planning differs — which is why knowing the exact tumor type matters. [1]
Is cholangiocarcinoma curable?
Cholangiocarcinoma can be, in some cases. Surgery to remove the cancer offers the best chance of cure when the tumor is found early enough. For certain cases of hilar cholangiocarcinoma, liver transplant can be a cure — although there is a risk the cancer will recur afterward. Because the disease is often advanced at diagnosis, many treatments instead aim to slow the cancer and relieve symptoms. [2]
Why is bile duct cancer usually found so late?
Early-stage bile duct cancer often produces few or no symptoms, and the bile ducts sit deep inside the abdomen where tumors are hard to detect. The classic symptom — jaundice — usually appears only after a tumor has grown enough to block bile flow, which is often at an advanced stage. [1] [2]
Can a biopsy affect whether I can get a liver transplant?
Yes — and this is an important question to raise before biopsy. If bile duct cancer is biopsied by fine-needle aspiration (a needle through the skin into the tumor), you become ineligible for liver transplantation. Biopsies obtained during ERCP near the intestine do not carry this restriction. Your care team should weigh this carefully when transplant is a possibility. [2]
This article is for general education and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional about your individual situation.
What are the first signs of bile duct cancer?
Early bile duct cancer often causes no symptoms. When symptoms appear, they may include yellow skin or eyes, itchy skin, dark urine, pale stools, belly pain and weight loss.
Who is at higher risk of cholangiocarcinoma?
Risk is higher in people with primary sclerosing cholangitis, chronic liver disease, bile duct cysts, or liver fluke infection. Many people with cholangiocarcinoma have no known risk factor.
How is cholangiocarcinoma diagnosed?
Doctors use imaging tests such as CT, MRI or MRCP, blood tests including CA 19-9, and procedures such as ERCP. A biopsy is often needed to confirm the diagnosis.
What treatments are used if surgery is not possible?
Options can include chemotherapy, immunotherapy, targeted therapy, radiation and clinical trials. Doctors may also place a small tube called a stent to keep a blocked bile duct open and relieve jaundice.
Is cholangiocarcinoma hereditary?
Most cases are not inherited. Testing the tumor for certain gene changes is common, because the results can help choose targeted treatments.
Related Reading
MRCP (Magnetic Resonance Cholangiopancreatography): Purpose, Preparation and What to Expect explains the MRI scan used to image the bile and pancreatic ducts.
Learn more in our guide to Endoscopic Ultrasound (EUS): Uses, Procedure, Recovery and Risks.
CA 19-9 Blood Test: Uses, High Levels, Limits and Pancreatic Cancer explains the tumor marker test used for pancreatic and bile duct cancers.
References
Mayo Clinic Staff. Cholangiocarcinoma (bile duct cancer) - Symptoms and causes. Mayo Clinic. July 29, 2025. https://www.mayoclinic.org/diseases-conditions/cholangiocarcinoma/symptoms-causes/syc-20352408
Mayo Clinic Staff. Cholangiocarcinoma (bile duct cancer) - Diagnosis and treatment. Mayo Clinic. July 29, 2025. https://www.mayoclinic.org/diseases-conditions/cholangiocarcinoma/diagnosis-treatment/drc-20352413
National Cancer Institute. Bile duct cancer (cholangiocarcinoma) treatment (PDQ)–health professional version. Cancer.gov. March 28, 2025. https://www.cancer.gov/types/liver/hp/bile-duct-treatment-pdq
American Cancer Society. Bile duct cancer. American Cancer Society. Accessed October 14, 2026. https://www.cancer.org/cancer/types/bile-duct-cancer.html
Clements O, Eliahoo J, Kim JU, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a systematic review and meta-analysis. J Hepatol. 2020;72(1):95-103. PMID 31536748. https://doi.org/10.1016/j.jhep.2019.09.007
Oh DY, Ruth He A, Qin S, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer. NEJM Evid. 2022;1(8):EVIDoa2200015. PMID 38319896. https://doi.org/10.1056/EVIDoa2200015
Ciria R, Ivanics T, Aliseda D, et al. Liver transplantation for primary and secondary liver tumors: patient-level meta-analyses compared to UNOS conventional indications. Hepatology. 2025;81(6):1700-1713. PMID 39465987. https://doi.org/10.1097/HEP.0000000000001129
Comments